Restated* | |||
2023 | 2022 | ||
Note | £’000 | £’000 | |
Continuing operations: | |||
Revenue | 3 | ||
Operating expenses: | |||
Employee costs | 15 | ( | ( |
Depreciation on property, plant and equipment and right-of-use assets | 18 | ( | ( |
Other operating costs | ( | ( | |
Other (losses)/gains | 3 | ( | |
Share of post-tax (loss) from joint venture | 20 | ( | ( |
Share-based payments | 15 | ( | |
Amortisation of intangible assets | 17 | ( | ( |
Exceptional gains | 9 | ||
Exceptional costs | 9 | ( | ( |
Contingent consideration payable | 25 | ( | |
Group operating profit/(loss) | 4 | ( | |
Finance income | 7 | ||
Finance cost | 8 | ( | ( |
Net finance income/(cost) | ( | ||
Profit/(loss) before tax | ( | ||
Taxation | 16 | ( | |
Profit/(loss) for the period from continuing operations | ( | ||
Discontinued operations: | |||
Loss for period from discontinued operations | 6 | ( | ( |
Loss for the period | ( | ( | |
Attributable to: | |||
Owners of the parent | ( | ( | |
Non-controlling interest | ( | ( | |
( | ( | ||
Loss per share from total operations (expressed in pence per share): | |||
Basic | 12 | ( | ( |
Diluted | 12 | ( | ( |
Earnings/(loss) per share from continuing operations (expressed as pence per share): | |||
Basic | 12 | ( | |
Diluted | 12 | ( | |
*See note 36 for details regarding restatements. |
Restated* | |||
2023 | 2022 | ||
Note | £’000 | £’000 | |
Loss for the year | ( | ( | |
Items that will not to be reclassified to profit and loss in subsequent periods: | |||
Revaluation of financial assets not recycled through the income statement | ( | ( | |
Tax on revaluation | ( | ||
Total other comprehensive loss for the year, net of tax | ( | ( | |
Total comprehensive loss for the year, net of tax | ( | ( | |
Attributable to: | |||
Owners of the parent | ( | ( | |
Non-controlling interest | ( | ( |
Restated* | Restated* | |||
2023 | 2022 | 1 January 2022 | ||
£’000 | £’000 | £’000 | ||
Non-current assets | ||||
Goodwill | 17 | |||
Other intangible assets | 17 | |||
Property, plant and equipment and right-of-use assets | 18 | |||
Financial assets | 19 | |||
Deferred tax asset | 16 | |||
Investment in sublease | 19 | |||
Investment in joint venture | 20 | |||
Contract assets | 21 | |||
Loans to franchisees and appointed representatives | 19 | |||
Total non-current assets | ||||
Current assets | ||||
Trade and other receivables | 22 | |||
Financial assets | 19 | |||
Contract assets | 21 | |||
Investment in sublease | 19 | |||
Current tax assets | 16 | |||
Loans to franchisees and appointed representatives | 19 | |||
Cash and cash equivalents | 23 | |||
Assets held for sale | ||||
Total current assets | ||||
Total assets | ||||
Current liabilities | ||||
Financial liabilities | 25 | ( | ( | ( |
Trade and other payables | 24 | ( | ( | ( |
Provisions for liabilities | 26 | ( | ( | ( |
Bank overdrafts | 23 | ( | ( | ( |
( | ( | ( | ||
Liabilities held for sale | ( | |||
Total current liabilities | ( | ( | ( | |
Non-current liabilities | ||||
Financial liabilities | 25 | ( | ( | ( |
Deferred tax liability | 16 | ( | ( | |
Provisions for liabilities | 26 | ( | ( | ( |
Total non-current liabilities | ( | ( | ( | |
Total liabilities | ( | ( | ( | |
Net assets | ||||
Equity | ||||
Share capital | 28 | |||
Share premium account | 29 | |||
Share-based payment reserve | 29 | |||
Shares held by employee benefit trust and share incentive plan | 2,29 | ( | ( | ( |
Treasury shares | 29 | ( | ( | |
Fair value reserve | 29 | ( | ( | ( |
Retained earnings | ||||
Total equity attributable to owners of the parent | ||||
Non-controlling interest | ( | |||
Total equity |
Restated* | |||
2023 | 2022 | ||
Note | £’000 | £’000 | |
Profit/(loss) before tax from continuing operations | ( | ||
Loss before tax from discontinued operations | ( | ( | |
Loss before tax | ( | ( | |
Adjustments for: | |||
Exceptional costs | |||
Exceptional gains | ( | ( | |
Contingent consideration payable | ( | ||
Depreciation of tangible assets | 18 | ||
Amortisation of intangible assets | 17 | ||
Share-based payments | 6,15 | ( | |
Loss on disposal of property, plant and equipment and right-of-use assets | 6 | ( | ( |
Loss from joint venture | 20 | ||
Recognition of investments at fair value through the income statement | 19 | ( | |
Decrease in contract assets | 21 | ||
Finance income | 7 | ( | ( |
Finance costs | 6,8 | ||
Operating cash flows before movements in working capital | |||
Movements in working capital | |||
Decrease/(increase) in trade and other receivables | ( | ||
Decrease in trade and other payables | ( | ( | |
Increase/(decrease) in provisions | ( | ||
( | ( | ||
Cash generated from operations | |||
Interest paid (leases) | 27 | ( | ( |
Interest received (leases) | 27 | ||
Income taxes paid | ( | ||
Exceptional costs paid | ( | ( | |
Net cash (expended)/generated from operating activities | ( | ||
Cash flows used in investing activities | |||
Interest received | |||
Disposal of businesses, net of cash disposed | |||
Payment of contingent consideration | 25 | ( | ( |
Investment in joint venture | 20 | ( | ( |
Proceeds from sale of financial assets | 19 | ||
Franchisees and appointed representatives loans granted | 19 | ( | |
Franchisees and appointed representatives loan repayments | 19 | ||
Receipt of lease income | 27 | ||
Purchase of property, plant and equipment and intangible assets | 17,18 | ( | ( |
Proceeds from sale of property, plant and equipment | 18 | ||
Net cash generated/(expended) on investing activities | ( | ||
Cash flows used in financing activities | |||
Purchase of LSL shares by the employee benefit trust | ( | ||
Repurchase of treasury shares | ( | ||
Proceeds from exercise of share options | 15 | ||
Payment of lease liabilities | 14 | ( | ( |
Dividends paid | 13 | ( | ( |
Net cash expended in financing activities | ( | ( | |
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the beginning of the year | 23 | ||
Cash and cash equivalents at the end of the year | 23 |
Equity | ||||||||||
Share- | Shares | attributable | ||||||||
Share | based | held by | to owners | Non- | ||||||
Share | premium | payment | EBT and | Treasury | Fair value | Retained | of the | controlling | Total | |
capital | account | reserve | SIP | shares | reserve | earnings | parent | interest | equity | |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
At 1 January 2023 | ( | ( | ( | |||||||
Loss for the year | ( | ( | ( | ( | ||||||
Revaluation of financial assets | ( | ( | ( | |||||||
Tax on revaluations | ( | ( | ( | |||||||
Total comprehensive loss for the year | ( | ( | ( | ( | ( | |||||
Acquisition of non-controlling interests | ( | |||||||||
Exercise of options | ( | ( | ||||||||
Vested share options lapsed | ||||||||||
during the year | ( | |||||||||
Dividend paid | ( | ( | ( | |||||||
Fair value reclassification | ||||||||||
following disposals | ( | |||||||||
Share-based payments | ( | ( | ( | |||||||
Tax on share-based payments | ( | ( | ( | |||||||
At 31 December 2023 | ( | ( | ( | ( | ||||||
During the period, Employee Benefit Trust. LSL received £nil on exercise of these options. | ||||||||||
The notes on pages 128 to 180 form part of these Financial Statements. | ||||||||||
Group Statement of Changes in Equity | ||||||||||
for the year ended 31 December 2022 | Equity | |||||||||
Share- | Shares | attributable | ||||||||
Share | based | held by | to owners | Non- | ||||||
Share | premium | payment | EBT and | Treasury | Fair value | Retained | of the | controlling | Total | |
capital | account | reserve | SIP | shares | reserve | earnings | parent | interest | equity | |
£’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
At 1 January 2022 | ( | ( | ||||||||
Prior year restatements | ||||||||||
(net of tax)* | ( | ( | ( | |||||||
At 1 January 2022 (Restated) | ( | ( | ||||||||
Loss for the year (Restated) | ( | ( | ( | ( | ||||||
Revaluation of financial assets | ( | ( | ( | |||||||
Tax on revaluations | ||||||||||
Total comprehensive loss for the year | ( | ( | ( | ( | ( | |||||
Shares repurchased into treasury | ( | ( | ( | |||||||
Shares repurchased into EBT | ( | ( | ( | |||||||
Exercise of options | ( | ( | ||||||||
Dividend paid | ( | ( | ( | |||||||
Share-based payments | ||||||||||
Tax on share-based payments | ( | ( | ( | |||||||
At 31 December 2022 | ( | ( | ( |